Clinical Trials Browser

Phase NA × Breast Neoplasms × exemestane × Clear all

NCT01897441 2024-12-24

Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer

Phase NA Terminated

31 enrolled 11 charts

Breast Neoplasms

NCT00066586 2020-04-02

Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer

Phase NA Completed

Breast Neoplasms

NCT01720602 2020-01-07

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy

Phase NA Completed

15 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT02109913 2019-10-14

Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane

Phase NA Unknown

Breast Neoplasms, Neoplasm Metastasis

NCT01153672 2019-09-06

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy

Phase NA Completed

8 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01385280 2018-10-17

Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer

Phase NA Completed

13 enrolled 6 charts

Breast Neoplasms

NCT01331421 2018-01-23

Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions

Phase NA Completed

Breast Neoplasms

NCT01331434 2018-01-23

Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions

Phase NA Completed

Breast Neoplasms

NCT01331447 2018-01-23

Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions

Phase NA Completed

Breast Neoplasms

NCT01655004 2016-06-22

Prospective Study of UDP-gluconoryltransferase 2B17 Genotype as a Predictive Marker of Exemestane PK and PD

Phase NA Unknown

Breast Neoplasms